Portola Pharma Rips 20% Higher After FDA Approves Andexxa Antidote
May 04, 2018 at 14:14 PM EDT
Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares reclaimed the $40 level for the first time since February after a positive FDA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.